End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.5 CNY | -0.38% | +5.04% | +1.19% |
04-29 | New China Life Insurance Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-16 | New China Life Insurance Logs Over 57 Billion Yuan in Q1 Premium Income | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 131% by 2026.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company shows low valuation levels, with an enterprise value at 0.29 times its sales.
- The company's share price in relation to its net book value makes it look relatively cheap.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.19% | 11.07B | C | ||
+10.00% | 76.32B | B- | ||
+7.49% | 50.69B | B+ | ||
+1.39% | 48.13B | B | ||
+9.67% | 42.08B | B+ | ||
+6.53% | 39.7B | B+ | ||
+19.86% | 38.01B | B | ||
+2.28% | 29.79B | B | ||
-7.16% | 27.63B | B- | ||
-20.99% | 24.06B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 601336 Stock
- Ratings New China Life Insurance Company Ltd.